Amphetamine, Serum
The Urine Amphetamine Assay test is designed to detect the presence of the class of drugs termed amphetamines in human urine as a qualitative or semi-quantitative screening test. Amphetamines are a synthetic derivative of ephedrine. The most common amphetamines include d-amphetamine, d-metamphetamine, and d,l-amphetamine. This class of drugs acts as a stimulant for the central nervous system (CNS). Since amphetamines are known as CNS stimulants they are also one of the more common drugs of abuse. They are psychologically and physiologically addicting. Their side effects include excitement, alertness, euphoria, decreased appetite, and reduced sense of fatigue. At low doses the individual can experience irritability, anxiety, insomnia, blurred vision, increased blood pressure, and heart palpitations. Chronic high dose users may develop a psychosis that can be indistinguishable from acute schizophrenia. Amphetamines are rapidly absorbed from the gastrointestinal tract and widely distributed throughout the body. Amphetamines can remain detectable in urine 3-4 days after ingestion.
- Therapeutic monitoring
- Drug abuse evaluation
- Toxicity assessment
Negative (less than cutoff)
Cut-Off Ranges: Cut-Off values are used to determine the positivity of the urine specimen being analyzed. Cut-off values can vary based on the particular manufacturer of the assay.
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigeration: 7 days
- J Chromatogr B Biomed Sci Appl. 1998 Aug 21;713(1):163-87. [PMID: 9700558]
- J Chromatogr. 1992 Sep 16;580(1-2):77-95. [PMID: 1400833]
- Urine Testing for Drug Abuse. National Institute on Drug Abuse (NIDA) Research Monograph. 73, 1986.
- Mandatory Guidelines for Federal Workplace Drug Testing Programs. National Institute On Drug Abuse. Federal Register. Vol. 53. No 69, pp 1970 (1988)
- Kalant OJ. The Amphetamines Toxicity and Addiction. Thomas, Springfield. 151pp. 1966.